Ongoing debate about Gardasil (”HPV vaccine”)
Last week we posted some information about the human papillomavirus (HPV) and Gardasil, a vaccine that can prevent four strains of HPV that are related to many (but not all) cases of cervical cancer and genital warts. We mentioned that Gardasil, like other vaccines, has not been received without controversy. The New York Times recently reported on some of the issues around the marketing of Gardasil and how the media (and its manufacturers' marketing efforts) have contributed to occasional misinformation - or overhyped claims - about the vaccine. You can read the NYT article on their web site (free registration required).
Dr. Debby Herbenick
